IP Library Granted Patent US 7,202,363
Granted Patent B2
US 7,202,363 · App. 10/899,168 · Granted Apr 10, 2007

Thienopyridine and furopyridine kinase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,363
App. No.
10/899,168
Granted
Apr 10, 2007
Kind
B2
Abstract

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Claims (23)

1. A compound of formula (I)

or a therapeutically acceptable salt thereof, wherein

X is selected from the group consisting of O and S;

Z is C;

R 1 is selected from the group consisting of NR a R b , (NR a R b )alkenyl, (NR a R b )alkyl, (NR a R b )alkynyl, (NR a R b )carbonyl, (NR a R b )carbonylalkenyl, (NR a R b )carbonylalkyl, and (NR a R b )carbonylalkynyl;

R 2 is selected from the group consisting of hydrogen and alkyl;

R 3 is aryl wherein the aryl is optionally substituted with one, two, or three substituents independently selected from the group consisting of alkoxy, alkyl, aryl, cyano, halo, haloalkoxy, haloalkyl, hydroxy, hydroxyalkyl, LR 4 , and NR a R b ; provided that at least two of the three substituents are other than LR 4 ;

L is selected from the group consisting of O, (CH 2 ) m C(O)NR 5 , NR 5 C(O)(CH 2 ) m , NR 5 SO 2 , SO 2 NR 5 , (CH 2 ) m N(R 5 )C(O)N(R 6 )(CH 2 ) n , and (CH 2 ) m N(R 5 )C(S)N(R 6 )(CH 2 ) n , wherein m and n are independently 0 or 1, and wherein each group is drawn with its right end attached to R 4 ;

R 4 is selected from the group consisting of aryl and arylalkyl;

R 5 and R 6 are independently selected from the group consisting of hydrogen and alkyl;

R a and R b are independently selected from the group consisting of hydrogen, alkyl, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkyl, alkylcarbonyl, alkylsulfanylalkyl, alkylsulfonyl, aryl, arylalkoxycarbonyl, arylalkoxycarbonylalkyl, arylalkyl, arylcarbonyl, and arylsulfonyl, wherein the aryl and the aryl part of the arylalkoxycarbonyl, the arylalkoxycarbonylalkyl, the arylalkyl, the arylcarbonyl, and the arylsulfonyl can be further optionally substituted with one, two, three, four, or five substituents independently selected from the group consisting of alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkylcarbonyl, aryl, arylalkyl, halo, haloalkoxy, haloalkyl, hydroxy, nitro, NR c R d , (NR c R d )alkyl, (NR c R d )alkylcarbonyl, (NR c R d )carbonyl, and (NR c R d )carbonylalkyl, wherein the aryl and the aryl part of the arylalkyl can be substituted with one, two, three, four, or five substituents independently selected from the group consisting of alkoxy, alkyl, cyano, halo, haloalkoxy, haloalkyl, nitro, and oxo;

R c and R d are independently selected from the group consisting of hydrogen, alkoxy, alkyl, aryl, carboxyalkyl, haloalkyl, hydroxyalkoxyalkyl, hydroxyalkyl, and (NR c R d )alkyl, wherein the aryl can be optionally substituted with one, two, three, four, or five substituents independently selected from the group consisting of alkenyl, alkoxy, alkyl, halo, haloalkoxy, haloalkyl, hydroxy, and nitro; and

R e and R f are independently selected from the group consisting of hydrogen and alkyl.

2. The compound of claim 1 wherein R 3 is aryl, wherein the aryl is substituted with LR 4 and optionally with one or two additional substituents independently selected from the group consisting of alkoxy, alkyl, aryl, cyano, halo, haloalkoxy, haloalkyl, hydroxyalkyl, and NR a R b .

3. The compound of claim 2 wherein L is O.

4. The compound of claim 2 wherein L is selected from the group consisting of NR 5 C(O)(CH 2 ) m and NR 5 SO 2 .

5. The compound of claim 4 wherein R 1 is (NR a R b )alkenyl.

6. The compound of claim 2 wherein L is (CH 2 ) m N(R 5 )C(O)N(R 6 )(CH 2 ) n .

7. The compound of claim 6 wherein R 1 is (NR a R b )alkynyl.

8. The compound of claim 6 wherein R 1 is (NR a R b )carbonylalkenyl.

9. A compound selected from the group consisting of

N-(4-{4-amino-7-[3-(diethylamino)-1-propynyl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-methylphenyl)urea; and

N-(4-{4-amino-7-[3-(methylamino)-1-propynyl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-methylphenyl)urea.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030182/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2004
From: BETSCHMANN, PATRICK; BURCHAT, ANDREW F.; CALDERWOOD, DAVID J.; CURTIN, MICHAEL L.; DAVIS, HEATHER M.; HEYMAN, HOWARD R.; DAVIDSEN, STEVEN K.; FREY, ROBIN R.; HIRST, GAVIN C.; HMCIAR, PETER; MUCKEY, MELANIE A.; WADA, CAROL K.; MICHAELIDES, MICHAEL
To: ABBOTT LABORATORIES
Reel/Frame 015297/0637 →